Taymour Hammoudi, MD, PhD

Provider's Specialties

Hematology/Oncology - Pediatric
Pediatrics

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Patient ratings and reviews are not available

Why?

Center for Cancer and Blood Disorders

(720)777-6740

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

My care philosophy

I believe in empowering patients and caregivers by treating them as a whole, providing maximal information possible, leaving no questions unanswered, and adhering to values of honesty, integrity, and humility. I will be fully engaged with you and your caregivers to provide the best possible care.

Get to know Taymour Hammoudi, MD, PhD

Departments and Programs

Conditions Treated

Blood and Marrow Transplant
Cancer Medicine
Pediatric Cancer

Languages spoken

English

Experience and background

My clinical interests are in providing comprehensive care through transplant and therapy to treat cancer in children and young adults.

Undergraduate 2005

North Carolina State University (NC)

Graduate 2014

Emory University

Graduate 2014

Georgia Institute Of Technology

Medical Education 2014

Emory University School of Medicine

Residency 2017

University of California (San Francisco) School of Medicine Program

Fellowship 2021

University of California (San Francisco) School of Medicine Program

Fellowship 2023

Duke University Hospital Program

For Patients:
My clinical interests are in leveraging patients' existing or transplanted immune system to treat pediatric and young adult cancers. This dovetails with my research interests, which are primarily focused on: (1) profiling and understanding the immune microenvironment of pediatric malignancies; and (2) improving our understanding of how we harness, optimize and drive an augmented immune system after transplant to treat cancer.

For Referring Providers:
My aim as a clinical-translational investigator is to leverage expertise in immunology, cell and tissue engineering, data science, machine-learning, clinical informatics, and pediatric oncology toward the design and implementation of early and late phase clinical trials centered on cellular and immuno-oncology therapeutics for pediatric and young adult oncology patients so that they may better survive and thrive. My clinical and translational research focuses on developing, implementing and refining cell transplant (SCT) and immune effector cell (IEC) therapies in collaboration with basic scientists and translating novel therapeutic strategies that promote optimal immune reconstitution and function for improving relapse-free survival and long term cure for children with malignancies, marrow failure and disorders of immunity (including discovering biomarkers, applying correlative studies, and evaluating outcomes).

T32 Training Award, Research Training in Childhood Cancer 2018

The T32 CA128583 training award from the National Cancer Institute (NCI) supports a structured pre-doctoral and/or post-doctoral training program in Translational Cancer Biology (TCB), with the primary goal of preparing trainees to become independent investigators capable of conducting high-impact cancer research. The program emphasizes rigorous coursework, mentored research in relevant biological models, interdisciplinary collaboration, and exposure to the full translational spectrum from molecular mechanisms to clinical applications.
National Cancer Institute, NIH

Pediatric Research Scholar 2021

The Duke Pediatric Research Scholars Program (DPRS) at Duke University School of Medicine is a physician-scientist training pathway designed to help pediatric residents and fellows transition into academic investigator roles, by combining intensive clinical training at Duke Children’s Hospital & Health Center with robust research experiences in Duke’s laboratories. Participants receive concierge mentoring, professional development seminars, scholarly engagement opportunities, and research support including funding and travel for presentations.
Duke University School of Medicine

Robert J Leftkowitz Society for Physician Scientists, Member 2022

The Robert J. Lefkowitz Society at Duke University School of Medicine provides a supportive community for MD and MD/PhD residents and fellows who are pursuing careers as physician-investigators focused on basic and translational research. Membership is by selection (5-10 new members annually), includes mentorship with senior physician-scientists, networking events (including dinners), and opportunities for scientific and career development throughout one’s training.
Duke University School of Medicine

Page Scholar 2025

The CIBMTR Page Scholars Program is a two-year initiative designed to immerse early-career investigators (typically 3-7 years post-fellowship) in the workings of CIBMTR’s Working Committees, giving them mentorship, leadership exposure, data-access experience and roles in protocol oversight. The program was launched in 2023 (initially called the Working Committee Training & Leadership Program), and was renamed in honor of the late Kristin Page Chartrand to reflect her dedication to career development and research leadership.
Center for International Blood and Marrow Transplant Research (CIBMTR)